Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > Wow , Paulson &Eco buying VRX to 12.5%
View:
Post by mtgfree1 on Aug 15, 2017 11:38am

Wow , Paulson &Eco buying VRX to 12.5%

Going well over $25
Comment by mtgfree1 on Aug 15, 2017 11:39am
They will make an 21.8 million shares 
Comment by mtgfree1 on Aug 17, 2017 8:39am
news Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility T.VRX | 2 hours ago PR Newswire LAVAL, Quebec, Aug. 16, 2017 LAVAL, Quebec, Aug. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced the U.S. Food and Drug Administration  ...more  
Comment by mtgfree1 on Aug 17, 2017 12:14pm
They know share price is going to make more than 6% bonds they sold to buy shares 
Comment by mtgfree1 on Aug 18, 2017 3:34pm
Next week $20+
Comment by mtgfree1 on Aug 15, 2017 11:41am
Going to be very interesting with controlling the company invents by Paulson
Comment by CarriePalmer on Aug 15, 2017 1:19pm
Where are you seeing this info?
Comment by mtgfree1 on Aug 15, 2017 8:05pm
See user Vrx in your bank , puts were at the highest of the market in VRX  10 times the volume in bit vs ask s news release of that is oven in stock house 
Comment by CarriePalmer on Aug 15, 2017 9:30pm
Great thanks @mtgfree1
Comment by domcolumba on Aug 16, 2017 11:59am
Aug 14, 2017 BRIEF-Paulson & Co dissolves share stake in Pfizer, ups in Valeant ‍ 5:12PM ET on Monday Aug 14, 2017 by Thomson Reuters   Aug 14 (Reuters) - Paulson & Co Inc : * Paulson & Co dissolves share stake in Pfizer- SEC filing ‍ * Paulson & Co Inc raises share stake in Valeant Pharmaceuticals by 12.5 percent to 21.8 million ...more  
Comment by mtgfree1 on Aug 17, 2017 8:38am
BRIEF-Paulson & Co dissolves share stake in Pfizer, ups in Valeant ‍  5:12PM ET on Monday Aug 14, 2017 by Thomson Reuters   Aug 14 (Reuters) - Paulson & Co Inc : * Paulson & Co dissolves share stake in Pfizer- SEC filing ‍ * Paulson & Co Inc raises share stake in Valeant Pharmaceuticals by 12.5 percent to 21.8 million shares ‍ * ‍Paulson ...more  
Comment by mtgfree1 on Aug 16, 2017 9:24am
Pauson sold 6% guaranteed on investment to buy shares that means they know shares will make more than 6%
Comment by mtgfree1 on Aug 16, 2017 10:10am
Check in your bank under VRX , it shows puts are at the Hughes in the market on VRX , 11 times higher bids vs ask . It tells on Paulson managed founds that is increasing its stake in VRX and selling Pfizer 
Comment by mtgfree1 on Aug 16, 2017 10:19am
I expect run to $25 before take sideway for a week  new 52 week high by earnings day 
Comment by mtgfree1 on Aug 16, 2017 10:59am
mtgfree1 RE:Wow , Paulson &Eco buying VRX to 12.5% Going to be very interesting with controlling the company invents by Paulson
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities